Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

How shorter sleep changes blood pressure responses

Official title: Impact of Sleep Restriction on Blood Pressure Reactivity

Run by University of Missouri-Columbia · NCT07489417 · Data updated 2026-11-12

We will test whether shorter nightly sleep changes blood pressure responses in healthy 18–45-year-olds who are either normal weight or have obesity.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment45 (estimated)
SponsorUniversity of Missouri-Columbia
Academic / other
Locations1 site (Columbia, Missouri)
StatusRecruiting
StartedMarch 4, 2026
Main results expectedAugust 2027
Study endsAugust 2027
Registry record updatedJuly 28, 2026
Trial IDNCT07489417 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy non-smoking adults 18–45 years old, premenopausal if female, who habitually sleep 7–9 hours and have either BMI <25 kg/m² or ≥30 kg/m².

Probably not a fit

People with hypertension, significant medical conditions, current medications that affect sleep or cardiovascular function, pregnancy, breastfeeding, nicotine use, irregular sleep, or diagnosed sleep disorders like sleep apnea are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Healthy men and premenopausal women aged 18–45 who report habitual 7–9 hours of sleep and meet BMI criteria for either normal weight or obesity will be enrolled. Participants undergo sleep restriction as the intervention with physiological monitoring to measure blood pressure reactivity and cardiovascular responses. People taking medications or with medical conditions affecting sleep or cardiovascular function are excluded to isolate the effect of sleep duration. All visits and sleep procedures are conducted on-site at the University of Missouri–Columbia.

Why it matters

Potential benefit: If successful, the results could show that shortened sleep directly increases blood pressure responses and help shape sleep recommendations to reduce cardiovascular risk.

How similar studies have gone: Observational studies have linked short sleep to higher blood pressure, but controlled sleep-restriction intervention data in healthy adults are limited, so this work builds on suggestive prior findings rather than established interventions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy adult men and women
* 18-45 years of age
* BMI \< 25 kg/m² (normal weight group) or ≥ 30 kg/m² (obesity group)
* Non-pregnant, non-breastfeeding, and non-nicotine users
* Self-reported history of normal sleep duration (7-9 hours/night) and bedtime prior to midnight
* Premenopausal

Exclusion Criteria:

* No acute or chronic conditions
* Taking no medications known to affect sleep, autonomic, metabolic, or cardiovascular function
* Self-reported history of irregular sleep
* Self-reported history of hepatic, renal, pulmonary, cardiovascular, or neurological disease, stroke or neurovascular disease, bleeding/clotting disorders, sleep apnea or other sleep disorders, diabetes, history of alcoholism or substance abuse, major cardiovascular event or surgical procedure within the past three months, or hypertension

Where it's running

  • University of Missouri
    Columbia, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.